Skip to main content

Table 3 Magnesium administration and the incidence and type of arrhythmias compared to placebo

From: Evaluating the effect of magnesium supplementation and cardiac arrhythmias after acute coronary syndrome: a systematic review and meta-analysis

Type of fractures

Summary odds ratio (OR)

95% confidence interval

Between studies

I2

p for

heterogeneity

Ventricular tachycardia

Ventricular fibrillation

Total of Ventricular arrhythmia

0.65

0.69

0.38

0.50–0.85

0.47–1.01

0.23–0.64

55.6%

48.9%

79.0%

0.035

0.098

0.000

Atrial Fibrillation

Supraventricular tachycardia

Total of Supraventricular arrhythmia

0.46

0.48

0.43

0.28–0.76

0.33–0.70

0.28–0.65

76.9%

48.5%

73.4%

0.000

0.084

0.000

Bradycardia

1.29

0.99–1.69

12.7

0.329

Total Arrhythmia

0.41

0.29–0.58

82.1

0.000